The U.S. is rolling out Pfizer and Merck’s COVID-19 antivirals to states but ‘complex’ manufacturing process may limit launch
December 28, 2021 at 11:25 AM EST
The U.S. has started shipping some doses of the recently authorized COVID-19 antivirals developed by Pfizer and Merck.
